United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 4th. The shares were sold at an average price of $227.97, for a total transaction of $1,367,820.00. Following the completion of the transaction, the executive vice president now […]